Signal #164519 · SEC 8-K

$BRVE SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $BRVE filing catalyst

Why did $BRVE trigger an AI stock catalyst alert?

$BRVE triggered a Stock Catalyst AI alert on 2026-11-06 20:17:17 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Braveheart Bio Reports Positive 52-Week Phase 2 Data for HRS/BHB-1893 in oHCM. Key points: - Phase 2 OLE showed mean pVO2 improvement of 2.7 mL/kg/min and KCCQ-CSS increase of 17.3 points at Week 52. - 79% of patients achieved Valsalva LVOT gradient below 30 mmHg; 60% reached NYHA Class I. - Simplified dosing supported, with 57% remaining on initial 40 mg BID dose.

How did $BRVE stock react after the SEC filing?

After the SEC 8-K for $BRVE, observed market reaction: T0 price $18.26; peak move +0.33%. Past moves do not guarantee future results.

Where can I get real-time $BRVE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $BRVE via Telegram and the VIP Web Terminal from €10/month.

$BRVE

$BRVE – Braveheart Bio Reports Positive 52-Week Phase 2 Data for HRS/BHB-1893 in oHCM

Braveheart Bio, Inc.

2026-11-06 20:17:17 UTC · SEC 8-K · All $BRVE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Phase 2 OLE showed mean pVO2 improvement of 2.7 mL/kg/min and KCCQ-CSS increase of 17.3 points at Week 52.
79% of patients achieved Valsalva LVOT gradient below 30 mmHg; 60% reached NYHA Class I.
Simplified dosing supported, with 57% remaining on initial 40 mg BID dose.

Observed market reaction after signal

Peak +0.33%

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →